Tuesday, October 27, 2020


Home Biotech
Immune Therapeutics Inc. (OTCMKTS:IMUN)

Immune Therapeutics Inc. (OTCMKTS:IMUN) Gearing For Lodonal Treatment Distribution In Ivory Coast & Nigeria

Immune Therapeutics Inc. (OTCMKTS:IMUN) Immune Therapeutics Inc. (OTCMKTS:IMUN) has signed a memorandum of understanding with GB Pharma Holdings and Rougier Pharma for the distribution of...
Cellceutix Corp (OTCMKTS:CTIX)

Cellceutix Corp (OTCMKTS:CTIX) Completes Patient Enrollment

Cellceutix Corp (OTCMKTS:CTIX) Cellceutix Corp (OTCMKTS:CTIX) has completed patient enrollment in its third and final Phase 3 open-label clinical trial for Brilacidin. The non-corticosteroid, non-biologic...
Medical Marijuana Inc. (OTCMKTS:MJNA)

Axim Biotechnologies Inc (OTCMKTS:AXIM) Soars After Analyst Issues $17 Price Target

Axim Biotechnologies Inc (OTCMKTS:AXIM) Shares of Axim Biotechnologies Inc (OTCMKTS:AXIM) experienced market gains after SeeThruEquity issued a price target of $17 per share. The new...

Bioelectronics Corp (OTCMKTS:BIEL) Expands Into Tesco In The UK Market

Bioelectronics Corp (OTCMKTS:BIEL) Bioelectronics Corp (OTCMKTS:BIEL) has announced an initial purchase order from Tesco for BioElectronics' ActiPatch® Musculoskeletal Pain Therapy devices. BioElectronics Corporation Vice President...

CytoDyn Inc (OTCMKTS:CYDY) Treats First Patient With PRO 140 In Phase 2 Trial

CytoDyn Inc (OTCMKTS:CYDY) CytoDyn Inc (OTCMKTS:CYDY) has announced treatment of the first patient in its Phase 2 clinical study examining Graft versus Host Disease- GvHD,...
Cannabis Science Inc (OTCMKTS:CBIS)

Cannabis Science Inc (OTCMKTS:CBIS) Releases First Test Batch Of Suppositories

Cannabis Science Inc (OTCMKTS:CBIS) Cannabis Science Inc (OTCMKTS:CBIS) has announced the release of its first cannabinoid-based suppositories for both male and female patients. The suppositories...